The latest Onconetix Inc (ONCO) stock price, news and insider information. Find out if you should buy Onconetix Inctoday with our review and forecast.

Onconetix, Inc. (Nasdaq: ONCO) (formerly Blue Water Biotech, Inc. (BWV)) is a commercial stage biotechnology company focused on the research, development and commercialization of proprietary therapeutics, diagnostics and services for clinicians and patients for oncology.

2023年3月21日 · 3月20日，OncoC4公司宣布与 BioNTech 签订合作协议，将共同开发旗下CTLA-4单抗ONC-392用于单药和与PD-1联用治疗多种实体瘤，计划在今年开展三期临床，OncoC4收到的价码是 2亿美元首付款 +若干里程碑付款+10%以上销售分成。 网页链接. OncoC4这个名字似乎有那么点陌生，看下官网上团队介绍就熟悉了，其实就是 刘阳 和 郑盼 伉俪此前创办的昂科免疫OncoImmune在两年多前被收购时分拆出的新公司。

Onconetix (ONCO) is a common stock listed on the NASDAQ exchange, which means you can buy the stock from most online brokers. Follow the steps below to learn how to purchase …

OncoGenerix USA, Inc. is proud to be the exclusive distributor of all the products and services provided by the state-of-the-art sterile injectable facility located in Mudanjiang, China. The facility has been designed and implemented to meet the quality requirements of …

Get the latest Onconetix, Inc. (ONCO) stock news and headlines to help you in your trading and investing decisions.

5 天之前 · Explore Onconetix stock price, quotes, charts and forecasts with Benzinga. Stay updated on market trends for ONCO. Onconetix Inc is a commercial-stage biotechnology …

Track Onconetix Inc (ONCO) Stock Price, Quote, latest community messages, chart, news and other stock related information. Share your ideas and get valuable insights from the community of like minded traders and investors

Onconetix, Inc. is a commercial stage biotechnology company, which engages in the research, development and commercialization of proprietary therapeutics, diagnostics and services for …

ONCO Options Chain, Max Pain, Calls, Puts, Volume, and Open Interest data. Calculate your ONCO options profitability odds and price.